Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Cell Death Discovery|December 15, 2022
Indole-3-carbinol in vitro antiviral activity against SARS-Cov-2 virus and in vivo toxicityFederica Centofanti, Tonino Alonzi, Andrea Latini, et al.
Frontiers in Immunology|September 23, 2022
Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapySaeid Najafi-Fard, Elisa Petruccioli, Chiara Farroni, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 12, 2020
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patientsLinda Petrone, Elisa Petruccioli, Valentina Vanini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 31, 2026
IRGM genetic variants associate with tuberculosis disease in a European populationTonino Alonzi, Assunta Navarra, Razaq Durodoye, et al.
Medicinal Research Reviews|August 5, 2026
Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host-Directed StrategiesTânia Silva, Alessandra Aiello, Tonino Alonzi, et al.
Cell Death & Disease|March 25, 2021
Inhibition of HECT E3 ligases as potential therapy for COVID-19Giuseppe Novelli, Jing Liu, Michela Biancolella, et al.
The European Respiratory Journal|June 27, 2020
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)Catherine Wei Min Ong, Giovanni Battista Migliori, Mario Raviglione, et al.
Pageof 6